- Home
- Publications
- Publication Search
- Publication Details
Title
New Insights in Anti-Angiogenesis in Multiple Myeloma
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 7, Pages 2031
Publisher
MDPI AG
Online
2018-07-12
DOI
10.3390/ijms19072031
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma
- (2018) Aurelia Lamanuzzi et al. Oncotarget
- Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study
- (2018) Luigia Rao et al. Oncotarget
- An overview of the role of carfilzomib in the treatment of multiple myeloma
- (2017) Dimitrios C. Ziogas et al. EXPERT OPINION ON PHARMACOTHERAPY
- Monoclonal Antibodies for the Treatment of Myeloma
- (2016) Sagar Lonial CANCER JOURNAL
- Integration of Novel Agents into the Care of Patients with Multiple Myeloma
- (2016) Robert Z. Orlowski et al. CLINICAL CANCER RESEARCH
- Immune Therapies in Multiple Myeloma
- (2016) Shaji K. Kumar et al. CLINICAL CANCER RESEARCH
- Targeting vasculogenesis to prevent progression in multiple myeloma
- (2016) M Moschetta et al. LEUKEMIA
- Role of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patients
- (2016) Aurelia Lamanuzzi et al. Oncotarget
- Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma
- (2015) Sagar Lonial et al. NEW ENGLAND JOURNAL OF MEDICINE
- CXCR4 Regulates Extra-Medullary Myeloma through Epithelial-Mesenchymal-Transition-like Transcriptional Activation
- (2015) Aldo M. Roccaro et al. Cell Reports
- Selective and Potent Akt Inhibition Triggers Anti-Myeloma Activities and Enhances Fatal Endoplasmic Reticulum Stress Induced by Proteasome Inhibition
- (2014) N. Mimura et al. CANCER RESEARCH
- A HGF/cMET Autocrine Loop Is Operative in Multiple Myeloma Bone Marrow Endothelial Cells and May Represent a Novel Therapeutic Target
- (2014) A. Ferrucci et al. CLINICAL CANCER RESEARCH
- Erythropoietin is involved in the angiogenic potential of bone marrow macrophages in multiple myeloma
- (2013) Annunziata De Luisi et al. ANGIOGENESIS
- Novel Targeting of Phospho-cMET Overcomes Drug Resistance and Induces Antitumor Activity in Multiple Myeloma
- (2013) M. Moschetta et al. CLINICAL CANCER RESEARCH
- Sorafenib in patients with refractory or recurrent multiple myeloma
- (2013) Anna Yordanova et al. HEMATOLOGICAL ONCOLOGY
- Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial
- (2013) Jesus San Miguel et al. LANCET ONCOLOGY
- Bone marrow fibroblasts parallel multiple myeloma progression in patients and mice: in vitro and in vivo studies
- (2013) M A Frassanito et al. LEUKEMIA
- Pomalidomide: the new immunomodulatory agent for the treatment of multiple myeloma
- (2013) A A Chanan-Khan et al. Blood Cancer Journal
- SIE, SIES, GITMO evidence-based guidelines on novel agents (thalidomide, bortezomib, and lenalidomide) in the treatment of multiple myeloma
- (2012) Giovanni Barosi et al. ANNALS OF HEMATOLOGY
- Macrophages and mesenchymal stromal cells support survival and proliferation of multiple myeloma cells
- (2012) Jaehyup Kim et al. BRITISH JOURNAL OF HAEMATOLOGY
- The 39th David A. Karnofsky Lecture: Bench-to-Bedside Translation of Targeted Therapies in Multiple Myeloma
- (2012) Kenneth C. Anderson JOURNAL OF CLINICAL ONCOLOGY
- Pomalidomide plus low-dose dexamethasone in myeloma refractory to both bortezomib and lenalidomide: comparison of 2 dosing strategies in dual-refractory disease
- (2011) M. Q. Lacy et al. BLOOD
- The selective adhesion molecule inhibitor Natalizumab decreases multiple myeloma cell growth in the bone marrow microenvironment: therapeutic implications
- (2011) Klaus Podar et al. BRITISH JOURNAL OF HAEMATOLOGY
- Intussusceptive microvascular growth in tumors
- (2011) Domenico Ribatti et al. CANCER LETTERS
- Lenalidomide Restrains Motility and Overangiogenic Potential of Bone Marrow Endothelial Cells in Patients with Active Multiple Myeloma
- (2011) A. De Luisi et al. CLINICAL CANCER RESEARCH
- Immunomodulatory effects of lenalidomide and pomalidomide on interaction of tumor and bone marrow accessory cells in multiple myeloma
- (2010) G. Gorgun et al. BLOOD
- Treatment of patients with relapsed/refractory multiple myeloma with lenalidomide and dexamethasone with or without bortezomib: prospective evaluation of the impact of cytogenetic abnormalities and of previous therapies
- (2010) M A Dimopoulos et al. LEUKEMIA
- Pomalidomide (CC4047) plus low dose dexamethasone (Pom/dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM)
- (2010) M Q Lacy et al. LEUKEMIA
- Induction of angiogenesis by normal and malignant plasma cells
- (2009) D. Hose et al. BLOOD
- Vascular endothelial growth factor inhibition is not an effective therapeutic strategy for relapsed or refractory multiple myeloma: a phase 2 study of pazopanib (GW786034): Table 1
- (2009) H. Miles Prince et al. BLOOD
- MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma
- (2009) A. M. Roccaro et al. BLOOD
- Macrophages are an abundant component of myeloma microenvironment and protect myeloma cells from chemotherapy drug-induced apoptosis
- (2009) Y. Zheng et al. BLOOD
- Gene Expression Profiling of Bone Marrow Endothelial Cells in Patients with Multiple Myeloma
- (2009) R. Ria et al. CLINICAL CANCER RESEARCH
- Bortezomib and zoledronic acid on angiogenic and vasculogenic activities of bone marrow macrophages in patients with multiple myeloma
- (2009) Michele Moschetta et al. EUROPEAN JOURNAL OF CANCER
- Pomalidomide (CC4047) Plus Low-Dose Dexamethasone As Therapy for Relapsed Multiple Myeloma
- (2009) Martha Q. Lacy et al. JOURNAL OF CLINICAL ONCOLOGY
- The role of monocytes-macrophages in vasculogenesis in multiple myeloma
- (2009) D Ribatti et al. LEUKEMIA
- Sorafenib, a dual Raf kinase/vascular endothelial growth factor receptor inhibitor has significant anti-myeloma activity and synergizes with common anti-myeloma drugs
- (2009) V Ramakrishnan et al. ONCOGENE
- Treatment of Relapsed/Refractory Multiple Myeloma
- (2009) Efstathios Kastritis et al. SEMINARS IN HEMATOLOGY
- Lenalidomide plus dexamethasone is more effective than dexamethasone alone in patients with relapsed or refractory multiple myeloma regardless of prior thalidomide exposure
- (2008) M. Wang et al. BLOOD
- Constitutive expression of IL-12R 2 on human multiple myeloma cells delineates a novel therapeutic target
- (2008) I. Airoldi et al. BLOOD
- Validation of PDGFR and c-Src tyrosine kinases as tumor/vessel targets in patients with multiple myeloma: preclinical efficacy of the novel, orally available inhibitor dasatinib
- (2008) A. M. L. Coluccia et al. BLOOD
- Alternate day pomalidomide retains anti-myeloma effect with reduced adverse events and evidence of in vivo immunomodulation
- (2008) Matthew J. Streetly et al. BRITISH JOURNAL OF HAEMATOLOGY
- Endothelial Differentiation of Hematopoietic Stem and Progenitor Cells from Patients with Multiple Myeloma
- (2008) R. Ria et al. CLINICAL CANCER RESEARCH
- Bone marrow angiogenesis and angiogenic factors in multiple myeloma treated with novel agents
- (2008) M. Teresa Cibeira et al. CYTOKINE
- Angiogenic activity of multiple myeloma endothelial cells in vivo in the chick embryo chorioallantoic membrane assay is associated to a down-regulation in the expression of endogenous endostatin
- (2008) Domenica Mangieri et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Lenalidomide inhibits osteoclastogenesis, survival factors and bone-remodeling markers in multiple myeloma
- (2008) I Breitkreutz et al. LEUKEMIA
- The anti-cancer drug lenalidomide inhibits angiogenesis and metastasis via multiple inhibitory effects on endothelial cell function in normoxic and hypoxic conditions
- (2008) Ling Lu et al. MICROVASCULAR RESEARCH
- Mast Cells Contribute to Vasculogenic Mimicry in Multiple Myeloma
- (2008) Beatrice Nico et al. STEM CELLS AND DEVELOPMENT
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started